{
 "Susceptible": {
 "Drug": {
 "Cefoxitin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [     37.5,     62.5 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
},
"Clindamycin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 42.85714, 57.14286 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
},
"Meropenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [     37.5,     62.5 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
},
"Metronidazole": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [     37.5,     62.5 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
},
"Piperacillin tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [     37.5,     62.5 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
},
"Tigecycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [     37.5,     62.5 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
} 
},
"percentage": [ 17.02128, 14.89362, 17.02128, 17.02128, 17.02128, 17.02128 ],
"weight": 0.9791667,
"backgroundColor": [ "#e31a1c", "#6a3d9a", "#bebada", "#fb8072", "#b3de69", "#fccde5" ] 
},
"Intermediate": {
 "Drug": null,
"percentage": null 
},
"Resistant": {
 "Drug": {
 "Clindamycin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Male" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
} 
},
"percentage":      100,
"weight": 0.02083333,
"backgroundColor": "#6a3d9a" 
} 
}
